Endovasc Inc. CEO To Attend BioEurope 2005; Management To Discuss Results Of European Phase II Liprostin Trials

MONTGOMERY, Texas--(BUSINESS WIRE)--Nov. 3, 2005--Endovasc, Inc - (OTCBB: EVSC) a Business Development Company focused on acquiring and investing in innovative drug development in the areas of cardiovascular and metabolic medicine, announced today that the Company’s President and CEO, Diane Dottavio, will be attending the Bio-Europe 2005 Conference in Dresden Germany, being held November 7-9, 2005.

MORE ON THIS TOPIC